Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease

Brain : a Journal of Neurology
W P GaiP C Blumbergs

Abstract

Characteristic ubiquitin-positive, tau-negative, degenerating neurites were present in brainstem regions known to be involved in idiopathic Parkinson's disease. Corresponding changes were entirely absent from controls and from the brainstems obtained from patients who had died with Alzheimer's disease, motor neuron disease and multiple system atrophy. In Parkinson's disease cases degenerating neurites were particularly striking in the dorsal motor nucleus of the vagus. In this nucleus the density of degenerating neurites was inversely related to the duration of Parkinson's disease symptoms. Some ubiquitin-positive degenerating neurites also contained neurofilament immunoreactivity. However, confocal microscopy revealed that ubiquitin and neurofilament reactivities were located in separate regions of the degenerating neurite, suggesting that proteins other than neurofilaments may be important in the process of ubiquitination. The demonstration of ubiquitin-positive degenerating neurites in routinely prepared paraffin-embedded material, particularly in the dorsal motor nucleus of the vagus, could become diagnostically useful in those Parkinson's disease cases in which Lewy bodies are difficult to find. Demonstration of extensive ...Continue Reading

Citations

Nov 13, 2004·Der Pathologe·D Sandmann-Keil, H Braak
Mar 11, 2008·Journal of Neural Transmission·R SakakibaraT Hattori
Aug 18, 1999·Journal of the Neurological Sciences·K WakabayashiH Takahashi
Jun 20, 2003·Neuropharmacology·Kumlesh K DevHerman van der Putten
Dec 8, 2000·Neuroscience Letters·K AraiT Hattori
Apr 18, 1998·Neuroscience Letters·K WakabayashiH Takahashi
Dec 13, 2000·Experimental Gerontology·B SommerM A Ruegg
Jul 10, 2003·Lancet Neurology·Ronald F Pfeiffer
Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Nov 16, 2006·Epilepsia·Marie-Noëlle Metz-Lutz, Melissa Filippini
Apr 6, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Yossef S LevyDaniel Offen
Aug 29, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Anne-Lenora HenriksenJohn T Tran
Sep 16, 2011·Parkinson's Disease·Ryuji SakakibaraTomonori Yamanishi
Jun 2, 2012·Expert Review of Neurotherapeutics·Glenda HallidayClaire Shepherd
Sep 5, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Heather McCannGlenda M Halliday
Nov 4, 2011·Neurobiology of Disease·Maria G Cersosimo, Eduardo E Benarroch
Oct 18, 2011·Journal of the Neurological Sciences·Maria G Cersosimo, Eduardo E Benarroch
Sep 1, 2011·Progress in Neurobiology·Philippe HuotJonathan M Brotchie
Dec 15, 2015·Neuropathology and Applied Neurobiology·Kelly Del Tredici, Heiko Braak
Sep 12, 2009·Journal of Comparative Pathology·M T CapucchioM Pumarola
May 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Susan H FoxJonathan M Brotchie
Dec 4, 2003·Journal of Neuroscience Research·Heike LaserMichael P Coleman
Jan 13, 2009·Journal of Neuroscience Methods·Matthew B SassRandolph A Coleman
Mar 3, 2004·Annals of Neurology·Eduardo E BenarrochJoseph E Parisi
Mar 18, 2009·The European Journal of Neuroscience·Franz MarxreiterBeate Winner
Nov 30, 2013·Journal of Neurochemistry·Ke WangWeihong Song
Jan 24, 1998·Brain Research·M M Tompkins, W D Hill
Mar 26, 2003·The Journal of Veterinary Medical Science·Kazuyuki UchidaSusumu Tateyama
Mar 7, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Viorica ChelbanHenry Houlden
Aug 13, 2017·Journal of Neuroscience Research·Lourdes Álvarez-ArellanoGustavo Pedraza-Alva
Sep 8, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Ann E KingsburyAndrew J Lees

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.